Leap Investments’s Aldeyra Therapeutics ALDX Stock Holding History

Leap Investments’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-13,200	Closed	-$79K	–	398
2019 Q2	$79K	Buy	+13,200	New	+$99.3K	0.11%	218

Other funds holding ALDX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Leap Investments's ALDX Position: Q3 2019 in Review

Leap Investments sold out of Aldeyra Therapeutics (ALDX) in Q3 2019, closing a stake of 13,200 shares — an estimated $79K sold.

Leap Investments first reported a position in ALDX in Q2 2019 and held it in 1 quarter. The position peaked at $79K in Q2 2019. 72 funds tracked by Wall St. Rank hold ALDX as of Q3 2019.

Leap Investments reported no remaining Aldeyra Therapeutics position as of Q3 2019 after selling out during the quarter.
Leap Investments sold 13,200 Aldeyra Therapeutics shares in Q3 2019, an estimated $79K.
Leap Investments first reported a position in Aldeyra Therapeutics in Q2 2019 and held it in 1 quarter.
Leap Investments's Aldeyra Therapeutics position peaked at $79K in Q2 2019.
72 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2019.

Based on Leap Investments's 13F filing for Q3 2019, filed 13 Nov 2019.